Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Forma Therapeutics Holdings, Inc. | SVP, Chief Scientific Officer | Common Stock | 41.5K | $209K | $5.05 | Feb 28, 2022 | Direct |
Forma Therapeutics Holdings, Inc. | SVP, Chief Scientific Officer | Stock Option (Right to Buy) | 37.5K | Feb 28, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FMTX | Forma Therapeutics Holdings, Inc. | Feb 28, 2022 | 2 | $0 | 4 | Mar 2, 2022 | SVP, Chief Scientific Officer |
FMTX | Forma Therapeutics Holdings, Inc. | Feb 23, 2022 | 1 | -$34.5K | 4 | Feb 25, 2022 | SVP, Chief Scientific Officer |